Spruce Biosciences

(NASDAQ) SPRB

Current Price$57.25

Market Cap$154.88M

Since IPO (2020)-96%

5 Year-95%

1 Year+943%

1 Month-18%

Spruce Biosciences Financials at a Glance

Market Cap

$154.88M

Revenue (TTM)

$0.00

Net Income (TTM)

$38.97M

EPS (TTM)

$-52.72

P/E Ratio

-1.09

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Price

$57.25

Volume

30,434.874

Open

$57.23

Price

$57.25

Volume

30,434.874

Open

$57.23

Previous Close

$57.28

Daily Range

$55.88 - $57.51

52-Week Range

$4.35 - $240.00

Dividend

$0.00

Beta (Volatility)

1.29 (Average)

Price

$57.25

Volume

30,434.874

Open

$57.23

Previous Close

$57.28

Daily Range

$55.88 - $57.51

52-Week Range

$4.35 - $240.00

SPRB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Spruce Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Javier Szwarcberg, MD

Website

sprucebio.com

Headquarters

Daly City, CA 94014, US

SPRB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-109%

Return on Capital

-85%

Return on Assets

-73%

Earnings Yield

-91.74%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$154.88M

Shares Outstanding

2.70M

Volume

30.43K

Avg. Volume

63.27K

Financials (TTM)

Gross Profit

$21.00K

Operating Income

$36.51M

EBITDA

$36.51M

Operating Cash Flow

$33.33M

Capital Expenditure

$0.00

Free Cash Flow

$33.33M

Cash & ST Invst.

$48.91M

Total Debt

$736.00K

Spruce Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$5.00K

-100.7%

Gross Margin

0.00%

N/A

Market Cap

$154.88M

N/A

Market Cap/Employee

$7.74M

N/A

Employees

N/A

Net Income

$14.65M

+37.8%

EBITDA

$11.10M

+52.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$48.17M

+33.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$419.00K

-51.3%

Short Term Debt

$317.00K

-83.4%

Return on Assets

-73.49%

N/A

Return on Invested Capital

-85.04%

N/A

Free Cash Flow

$6.46M

+68.8%

Operating Cash Flow

$6.46M

+68.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VTVTvTv Therapeutics Inc.

VTVTvTv Therapeutics Inc.$31.68-1.72%

CUECue Biopharma, Inc.

CUECue Biopharma, Inc.$30.42+106.38%

EQEquillium, Inc.

EQEquillium, Inc.$2.08+1.96%

COEPCoeptis Therapeutics, Inc.

COEPCoeptis Therapeutics, Inc.$16.40+0.00%

NRXPNRx Pharmaceuticals, Inc.

NRXPNRx Pharmaceuticals, Inc.$3.09+3.69%

HOWLWerewolf Therapeutics, Inc.

HOWLWerewolf Therapeutics, Inc.$0.72+0.47%

OTLKOutlook Therapeutics, Inc.

OTLKOutlook Therapeutics, Inc.$0.26+4.88%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About SPRB

What is the current price of Spruce Biosciences?

Spruce Biosciences is trading at $57.28 per share.

What is the 52-week range for Spruce Biosciences?

Over the past 52 weeks, Spruce Biosciences has traded between $4.35 and $240.00.

How much debt does Spruce Biosciences have?

As of the most recent reporting period, Spruce Biosciences reported total debt of $736,000.

How much cash does Spruce Biosciences have on hand?

Spruce Biosciences reported $48.91M in cash and cash equivalents in its most recent financial results.

What is Spruce Biosciences’s dividend yield?

Spruce Biosciences does not currently have a dividend yield.

Spruce Biosciences

Spruce Biosciences Financials at a Glance

SPRB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Spruce Biosciences

SPRB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Spruce Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SPRB

What is the current price of Spruce Biosciences?

What is the 52-week range for Spruce Biosciences?

How much debt does Spruce Biosciences have?

How much cash does Spruce Biosciences have on hand?

What is Spruce Biosciences’s dividend yield?

Premium Investing Services